Our aims are as follows: 1) to determine whether disclosure of elevated brain amyloid will
bias ADCS - PACC test results; 2) to determine whether disclosure of elevated brain amyloid will
cause psychological distress; and 3) to explore how learning amyloid imaging disclosure will impact preventative health behaviors, advance planning for health (e.g. long - term care insurance decisions) and well - being (e.g. stigma, quality of life and relationships).